Value20202021202220232024TTMCash from investing activities-15.5 K-50.62 K0-21.69 K-42.45 K-332.31 KCash from financing activities-114.6 M-26.2 M-45.96 M-43.42 M-43.46 M-43.62 MFree cash flow71.5 M11.44 M41.61 M94.78 M48.72 M116.31 M
SIGA Technologies Inc
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.